Mayne Pharma is an ASX-listed specialty pharmaceutical company focused on commercialising pharmaceuticals.

They have a 40-year track record of innovation and success developing new oral drug delivery systems and these technologies have been successfully commercialised in numerous products that continue to be marketed around the world.